236 related articles for article (PubMed ID: 16720922)
1. Pelvic exenteration for recurrent or persistent cervical cancer: experience of five years at the National Cancer Institute in Mexico.
Terán-Porcayo MA; Zeichner-Gancz I; del-Castillo RA; Beltrán-Ortega A; Solorza-Luna G
Med Oncol; 2006; 23(2):219-23. PubMed ID: 16720922
[TBL] [Abstract][Full Text] [Related]
2. Survival after curative pelvic exenteration for primary or recurrent cervical cancer: a retrospective multicentric study of 167 patients.
Chiantera V; Rossi M; De Iaco P; Koehler C; Marnitz S; Ferrandina G; Legge F; Parazzini F; Scambia G; Schneider A; Vercellino GF
Int J Gynecol Cancer; 2014 Jun; 24(5):916-22. PubMed ID: 24442006
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors for curative pelvic exenterations in patients with recurrent uterine cervical or vaginal cancer.
Sardain H; Lavoué V; Laviolle B; Henno S; Foucher F; Levêque J
Int J Gynecol Cancer; 2014 Nov; 24(9):1679-85. PubMed ID: 25254565
[TBL] [Abstract][Full Text] [Related]
4. Anterior pelvic exenteration.
Hatch KD; Shingleton HM; Soong SJ; Baker VV; Gelder MS
Gynecol Oncol; 1988 Sep; 31(1):205-16. PubMed ID: 3410348
[No Abstract] [Full Text] [Related]
5. Pelvic exenteration for adenocarcinoma of the uterine cervix.
Crozier M; Morris M; Levenback C; Lucas KR; Atkinson EN; Wharton JT
Gynecol Oncol; 1995 Jul; 58(1):74-8. PubMed ID: 7789894
[TBL] [Abstract][Full Text] [Related]
6. Indications for primary and secondary exenterations in patients with cervical cancer.
Marnitz S; Köhler C; Müller M; Behrens K; Hasenbein K; Schneider A
Gynecol Oncol; 2006 Dec; 103(3):1023-30. PubMed ID: 16890276
[TBL] [Abstract][Full Text] [Related]
7. [Outcomes of perisurgery and short-time follow-up of pelvic exenteration for 17 cases with locally recurrent cervical cancer].
Deng H; Wang JL; Wang ZQ; Li XW; Hu H; Yang B; Zhang XM; Shen K; Guo P; Liang B
Zhonghua Fu Chan Ke Za Zhi; 2020 Apr; 55(4):259-265. PubMed ID: 32375433
[No Abstract] [Full Text] [Related]
8. Pelvic exenteration for carcinoma of the cervix: analysis of 252 cases.
Rodriguez Cuevas H; Torres A; de la Garza M; Hernandez D; Herrera L
J Surg Oncol; 1988 Jun; 38(2):121-5. PubMed ID: 3288809
[TBL] [Abstract][Full Text] [Related]
9. [Post-radiotherapy pelvic exenteration in relapsed cervical cancer: experience of a tertiary health service in the northeast of Brazil].
Vieira SC; Costa DR; Meneses AD; Borges e Silva J; Oliveira AK; Sousa RB
Rev Bras Ginecol Obstet; 2009 Jan; 31(1):22-7. PubMed ID: 19347225
[TBL] [Abstract][Full Text] [Related]
10. Treatment of recurrent adenocarcinoma of the endometrium with pelvic exenteration.
Morris M; Alvarez RD; Kinney WK; Wilson TO
Gynecol Oncol; 1996 Feb; 60(2):288-91. PubMed ID: 8631553
[TBL] [Abstract][Full Text] [Related]
11. Exploratory laparotomy in recurrent cervical cancer.
Hardman AA; Daly JW
Obstet Gynecol; 1974 May; 43(5):653-7. PubMed ID: 4822649
[No Abstract] [Full Text] [Related]
12. Clinical and histopathologic factors predicting recurrence and survival after pelvic exenteration for cancer of the cervix.
Shingleton HM; Soong SJ; Gelder MS; Hatch KD; Baker VV; Austin JM
Obstet Gynecol; 1989 Jun; 73(6):1027-34. PubMed ID: 2726106
[TBL] [Abstract][Full Text] [Related]
13. Pelvic exenteration: long-term oncological results in a series of 106 patients.
De Wever I
Acta Chir Belg; 2011; 111(5):282-7. PubMed ID: 22191128
[TBL] [Abstract][Full Text] [Related]
14. Robotic-assisted laparoscopic exenteration in recurrent cervical cancer Robotics improved the surgical experience for 2 women with recurrent cervical cancer.
Davis MA; Adams S; Eun D; Lee D; Randall TC
Am J Obstet Gynecol; 2010 Jun; 202(6):663.e1. PubMed ID: 20510970
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcome of pelvic exenteration in patients with advanced or recurrent uterine cervical cancer.
Tanaka S; Nagase S; Kaiho-Sakuma M; Nagai T; Kurosawa H; Toyoshima M; Tokunaga H; Otsuki T; Utsunomiya H; Takano T; Niikura H; Ito K; Yaegashi N
Int J Clin Oncol; 2014 Feb; 19(1):133-8. PubMed ID: 23404487
[TBL] [Abstract][Full Text] [Related]
16. Postoperative radiotherapy for uterine cervical cancer: impact of lymph node and histological type on survival.
Kasuya G; Ogawa K; Iraha S; Nagai Y; Hirakawa M; Toita T; Kakinohana Y; Kudaka W; Inamine M; Ariga T; Aoki Y; Murayama S
Anticancer Res; 2013 May; 33(5):2199-204. PubMed ID: 23645776
[TBL] [Abstract][Full Text] [Related]
17. Pelvic exenteration for recurrent squamous cell carcinoma of the pelvic organs arising from the cloaca--a single institution's experience over 16 years.
Tan KK; Pal S; Lee PJ; Rodwell L; Solomon MJ
Colorectal Dis; 2013; 15(10):1227-31. PubMed ID: 23714581
[TBL] [Abstract][Full Text] [Related]
18. (Laterally) extended endopelvic resection: surgical treatment of locally advanced and recurrent cancer of the uterine cervix and vagina based on ontogenetic anatomy.
Höckel M; Horn LC; Einenkel J
Gynecol Oncol; 2012 Nov; 127(2):297-302. PubMed ID: 22864112
[TBL] [Abstract][Full Text] [Related]
19. [Pelvic exenteration, morbidity and survival].
Méndez L; Bernal A; Escudero P; González G; Fajardo A
Ginecol Obstet Mex; 1994 Jun; 62():161-5. PubMed ID: 8056362
[TBL] [Abstract][Full Text] [Related]
20. Anterior pelvic exenteration with total vaginectomy for recurrent or persistent genitourinary malignancies: review of surgical technique, complications, and outcome.
Andikyan V; Khoury-Collado F; Gerst SR; Talukdar S; Bochner BH; Sandhu JS; Abu-Rustum N; Sonoda Y; Barakat RR; Chi DS
Gynecol Oncol; 2012 Sep; 126(3):346-50. PubMed ID: 22555107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
